Home›Search›CNS Neuroscience and Therapeutics

CNS Neuroscience and Therapeutics

John Wiley and Sons Inc · United Kingdom · Est. 1966

ISSN1755-5949

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

136

days submission → published

measured · last 18 articles · accept 130d

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

1.741

H-Indexi

117

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

1.287

Total Worksi

3,987

Total Citationsi

93,140

2yr Mean Citednessi

4.92

Open Impact Factor alternative

Aims & Scope

Subject areas: Neurosciences; Pharmacology & Pharmacy; Pharmacology; Pharmacology (medical); Physiology (medical); Psychiatry and Mental Health.

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1966

FrequencyQuarterly

StatusActive (last: 2026)

Total Publications3,987

Publisher OrgWiley

OA Since2018

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~14 weeks

Acceptance Rate—

OA LicenseCC BY

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

John Wiley and Sons Inc

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1755-5949

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

179

7.6k

2019

143

5.4k

2020

203

4.9k

2021

296

2022

503

8.5k

2023

558

5.8k

2024

560

1.9k

2025

275

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

PharmacologyQ1

Pharmacology (medical)Q1

Physiology (medical)Q1

Psychiatry and Mental HealthQ1

Subject Classification

Web of Science Categories

NeurosciencesPharmacology & Pharmacy

Scopus Categories

PharmacologyPhysiology (medical)Pharmacology (medical)Psychiatry and Mental Health

Research Topics (OpenAlex)

Neuroinflammation and Neurodegeneration MechanismsNeuroscience and Neuropharmacology ResearchAlzheimer's disease research and treatmentsParkinson's Disease Mechanisms and TreatmentsFunctional Brain Connectivity StudiesNeurological disorders and treatmentsNeurological Disease Mechanisms and TreatmentsNeurogenesis and neuroplasticity mechanismsEpilepsy research and treatmentAcute Ischemic Stroke Management

Frequently asked questions about CNS Neuroscience and Therapeutics

Is CNS Neuroscience and Therapeutics a predatory journal?

PubScope has no integrity flags on record for CNS Neuroscience and Therapeutics: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of CNS Neuroscience and Therapeutics?

CNS Neuroscience and Therapeutics is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 4.92.

Is CNS Neuroscience and Therapeutics indexed in Scopus and Web of Science?

CNS Neuroscience and Therapeutics is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of CNS Neuroscience and Therapeutics?